EPSRC Centre for Doctoral Training in Advanced Engineering for Personalised Surgery & Intervention
Lead Research Organisation:
King's College London
Department Name: Imaging & Biomedical Engineering
Abstract
Our EPSRC CDT in Advanced Engineering for Personalised Surgery & Intervention will train a new generation of researchers for diverse engineering careers that deliver patient and economic impact through innovation in surgery & intervention. We will achieve this through cohort training that implements the strategy of the EPSRC by working across sectors (academia, industry, and NHS) to stimulate innovations by generating and exchanging knowledge.
Surgery is recognised as an "indivisible, indispensable part of health care" but the NHS struggles to meet its rising demand. More than 10m UK patients underwent a surgical procedure in 2021, with a further 5m patients still requiring treatment due to the COVID-19 backlog. This level of activity, encompassing procedures such as tumour resection, reconstructive surgery, orthopaedics, assisted fertilisation, thrombectomy, and cardiovascular interventions, accounts for a staggering 10% of the healthcare budget, yet it is not always curative. Unfortunately, one third of all country-wide deaths occur within 90 days of surgery. The Department of Health and Social Care urges for "innovation and new technology", echoing the NHS Long Term Plan on digital transformation and personalised care.
Our proposed CDT will contribute to this mission and deliver mission-inspired training in the EPSRC's Research Priority "Transforming Health and Healthcare". In addition to patient impact, engineering innovation in surgery and intervention has substantial economic potential. The UK is a leader in the development of such technology and the 3rd biggest contributor to Europe's c.150bn euros MedTech market (2021). The market's growth rate is substantial, e.g., an 11.4% (2021 - 2026) compound annual growth rate is predicted just for the submarket of interventional robotics.
The engineering scientists required to enhance the UK's societal, scientific, and economic capacity must be expert researchers with the skills to create innovative solutions to surgical challenges, by carrying out research, for example, on micro-surgical robots for tumour resection, AI-assisted surgical training, novel materials and theranostic agents for "surgery without the knife", and predictive computational models to develop patient-specific surgical procedures. Crucially, they should be comfortable and effective in crossing disciplines while being deeply engaged with surgical teams to co-create technology solutions. They should understand the pathway from bench-to-bedside and possess an entrepreneurial mindset to bring their innovations to the market. Such researchers are currently scarce, making their training a key contributor to the success of the UK Government's "Build Back Better - our plan for growth" and UKRI's "five-year strategy".
The cross-discipline collaboration of King's School of Biomedical Engineering & Imaging Sciences (BMEIS, host), Department of Engineering, and King's Health Partners (KHP), our Academic Health Science Centre, will create an engineering focused CDT that embeds students within three acute NHS Trusts. Our CDT brings together 50+ world-class supervisors whose grant portfolio (c.£150m) underpins the full spectrum of the CDT's activity, i.e., Smart Instruments & Active Implants, Surgical Data Science, and Patient-specific Modelling & Simulation.
We will offer MRes/PhD training pathway (1+3), and direct PhD training pathway (0+4). All students, regardless of pathway, will benefit from continuous education modules which cover aspects of clinical translation and entrepreneurship (with King's Entrepreneurship Institute), as well as core value modules to foster a positive research culture.
Our graduates will acquire an entrepreneurial mindset with skills in data science, fundamental AI, computational modelling, and surgical instrumentation and implants. Career paths will range from creating next generation medical innovators within academia and/or industry to MedTech start-up entrepreneurs.
Surgery is recognised as an "indivisible, indispensable part of health care" but the NHS struggles to meet its rising demand. More than 10m UK patients underwent a surgical procedure in 2021, with a further 5m patients still requiring treatment due to the COVID-19 backlog. This level of activity, encompassing procedures such as tumour resection, reconstructive surgery, orthopaedics, assisted fertilisation, thrombectomy, and cardiovascular interventions, accounts for a staggering 10% of the healthcare budget, yet it is not always curative. Unfortunately, one third of all country-wide deaths occur within 90 days of surgery. The Department of Health and Social Care urges for "innovation and new technology", echoing the NHS Long Term Plan on digital transformation and personalised care.
Our proposed CDT will contribute to this mission and deliver mission-inspired training in the EPSRC's Research Priority "Transforming Health and Healthcare". In addition to patient impact, engineering innovation in surgery and intervention has substantial economic potential. The UK is a leader in the development of such technology and the 3rd biggest contributor to Europe's c.150bn euros MedTech market (2021). The market's growth rate is substantial, e.g., an 11.4% (2021 - 2026) compound annual growth rate is predicted just for the submarket of interventional robotics.
The engineering scientists required to enhance the UK's societal, scientific, and economic capacity must be expert researchers with the skills to create innovative solutions to surgical challenges, by carrying out research, for example, on micro-surgical robots for tumour resection, AI-assisted surgical training, novel materials and theranostic agents for "surgery without the knife", and predictive computational models to develop patient-specific surgical procedures. Crucially, they should be comfortable and effective in crossing disciplines while being deeply engaged with surgical teams to co-create technology solutions. They should understand the pathway from bench-to-bedside and possess an entrepreneurial mindset to bring their innovations to the market. Such researchers are currently scarce, making their training a key contributor to the success of the UK Government's "Build Back Better - our plan for growth" and UKRI's "five-year strategy".
The cross-discipline collaboration of King's School of Biomedical Engineering & Imaging Sciences (BMEIS, host), Department of Engineering, and King's Health Partners (KHP), our Academic Health Science Centre, will create an engineering focused CDT that embeds students within three acute NHS Trusts. Our CDT brings together 50+ world-class supervisors whose grant portfolio (c.£150m) underpins the full spectrum of the CDT's activity, i.e., Smart Instruments & Active Implants, Surgical Data Science, and Patient-specific Modelling & Simulation.
We will offer MRes/PhD training pathway (1+3), and direct PhD training pathway (0+4). All students, regardless of pathway, will benefit from continuous education modules which cover aspects of clinical translation and entrepreneurship (with King's Entrepreneurship Institute), as well as core value modules to foster a positive research culture.
Our graduates will acquire an entrepreneurial mindset with skills in data science, fundamental AI, computational modelling, and surgical instrumentation and implants. Career paths will range from creating next generation medical innovators within academia and/or industry to MedTech start-up entrepreneurs.
Organisations
- King's College London (Lead Research Organisation)
- Alberto Recordati (Project Partner)
- Medtronic (United States) (Project Partner)
- FEOPS (Project Partner)
- Centre for AI and Robotics (CAIR) (Project Partner)
- Lightpoint Medical (United Kingdom) (Project Partner)
- Mesmerise Solutions UK Ltd (Project Partner)
- CMR Surgical Limited (Project Partner)
- The Urology Foundation (Project Partner)
- Ultromics Ltd (Project Partner)
- Leo Cancer Care UK (Project Partner)
- OT Bioelectronics SRL (Project Partner)
- Agency for Science, Technology and Research (Project Partner)
- Moorfields Eye Hospital NHS Foundation Trust (Project Partner)
- Proximie (Project Partner)
- Amber Therapeutics Ltd (Project Partner)
- Conceivable Life Sciences (Project Partner)
- HINDUJA FOUNDATION UK (Project Partner)
- Hypervision Surgical Ltd (Project Partner)
- Caranx Medical (Project Partner)
- TOIA LTD (Project Partner)
- Medyria AG (Project Partner)
- Zimmer and Peacock Ltd (Project Partner)
- Apeikon Therapeutics (Project Partner)
- Henry Royce Institute (Project Partner)
- Monogram Orthopedics (Project Partner)
- Ceryx Medical (United Kingdom) (Project Partner)
- Moon Surgical (Project Partner)
- BALLATER MEDICAL LTD (Project Partner)
- TCC-CASEMIX Limited (Project Partner)
- Soundsafe Care Srl (Project Partner)
- OPTO BIOSYSTEMS LTD (Project Partner)
- Innersight Labs (Project Partner)
- Cambridge Consultants (United Kingdom) (Project Partner)
- Inspire Foundation (Project Partner)
- Telos Health, Inc (Project Partner)
- Guy's and St Thomas' NHS Foundation Trust (Project Partner)
- Intuitive Surgical (United States) (Project Partner)
- Siemens Healthcare (Healthineers) Ltd (Project Partner)
Studentship Projects
Project Reference | Relationship | Related To | Start | End | Student Name |
---|---|---|---|---|---|
EP/Y035364/1 | 31/03/2024 | 29/09/2032 | |||
2930618 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Melissa Ng Tseung |
2930076 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Aban Merali |
2930150 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Marina Ivory |
2930165 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Yanghe Hao |
2930615 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Yanghe Hao |
2930162 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Adharvan Gabbeta |
2929686 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Melissa Ng Tseung |
2930603 | Studentship | EP/Y035364/1 | 30/09/2024 | 29/09/2028 | Un Hou Chan |